Compounds > tibolone
Page last updated: 2024-08-16

tibolone and norethindrone acetate

tibolone has been researched along with norethindrone acetate in 43 studies

Research

Studies (43)

TimeframeStudies, this research(%)All Research%
pre-19901 (2.33)18.7374
1990's1 (2.33)18.2507
2000's35 (81.40)29.6817
2010's6 (13.95)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kollman, PA; Lee, DL; Marsh, FJ; Wolff, ME1
Laird, SM; Lee, S; Li, TC; Okon, MA1
Agrawal, R; Conway, GS; Ginsburg, J; Jacobs, HS; Payne, NN; Prelevic, G1
Altkemper, R; Coelingh Bennink, HJ; Helmond, FA; Kwee, B; Winkler, UH1
Coelingh Bennink, HJ; Dören, M; Holzgreve, W; Rübig, A2
Guest, JF; Plumb, JM1
Bilgen, I; Bilgin, O; Coşan Terek, M; Memiş, A; Ozşener, S; Oztekin, K; Sendağ, F1
Azavedo, E; Barkfeldt, J; Christow, A; Kersemaekers, W; Lundström, E; Mol-Arts, M; Söderqvist, G; Svane, G; von Schoultz, B1
Karakus, C; Simsek, T; Trak, B1
Benhamou, CL; Garnero, P; Jamin, C; Pelissier, C; Roux, C1
Jamin, C; Madelenat, P; Poncelet, C1
Bonnar, J; Joyce, M; Norris, LA; O'Keeffe, N; Sheppard, BL1
Alpaslan, M; Fenkci, S; Fenkci, V; Onrat, E; Yilmazer, M1
Arabi, A; Benhamou, CL; Garnero, P; Pelissier, C; Porcher, R; Roux, C1
Aban, M; Atiş, S; Camdeviren, H; Kiliç, F; Pata, C; Pata, O; Tok, E; Utku Oz, A; Yazici, G1
Alatas, E; Demir, S; Kaleli, B; Yildirim, B1
Carlström, K; Christow, A; Conner, P; Kersemaekers, W; Mol-Arts, M; Skoog, L; Söderqvist, G; Tani, E; von Schoultz, B1
Botsis, D; Caramalis, G; Christodoulakos, G; Creatsas, G; Lambrinoudaki, I; Panoulis, C; Rizos, D; Sioulas, V1
Azavedo, E; Carlström, K; Hofling, M; Kloosterboer, H; Svane, G; Von Schoultz, B1
Griva, BL; Luca, LA; Morceli, J; Moriguchi, SM; Nahas, EA; Nahas-Neto, J; Traiman, P; Uemura, G1
Bernardi, F; Casarosa, E; Gabbanini, M; Genazzani, AD; Genazzani, AR; Luisi, M; Palumbo, M; Picciarelli, G; Pieri, M; Pluchino, N1
Bozkaya, H; Okumuş, B; Osmanağaoğlu, MA; Osmanağaoğlu, S; Osmanağaoğlu, T1
Franke, HR; Vermes, I; Werner, HM1
Andersen, TO; Eilertsen, AL; Qvigstad, E; Sandset, PM; Sandvik, L1
Arangino, S; Cagnacci, A; Cannoletta, M; Pirillo, D; Renzi, A; Volpe, A1
Christodoulakos, GE; Creatsas, GC; Economou, EV; Kouskouni, EE; Lambrinoudaki, IV; Panoulis, CP; Papadias, C; Vitoratos, N; Vlachou, SA1
Andersen, TO; Eilertsen, AL; Mowinckel, MC; Qvigstad, E; Sandset, PM; Sandvik, L1
Eilertsen, AL; Hemker, HC; Liestøl, S; Mowinckel, MC; Sandset, PM1
Alexandrou, AP; Bastounis, E; Bramis, J; Christodoulakos, GE; Creatsas, GC; Dalamanga, A; Keramaris, NC; Lambrinoudaki, IV1
Franke, HR; Hammar, ML; Nijland, EA; Pornel, B; van de Weijer, P; von Mauw, EM1
Alexandrou, AP; Christodoulakos, GE; Creatsas, GC; Economou, EV; Kouskouni, EE; Lambrinoudaki, IV; Panoulis, CP; Vlachou, SA1
Davis, SR; Helmond, FA; Mulder, RJ; Nathorst-Boös, J; Nijland, EA; Norman, RJ; Palacios, S; Van Lunsen, RH; Weijmar Schultz, WC1
Eilertsen, AL; Karssemeijer, N; Qvigstad, E; Sandset, PM; Skaane, P1
Bruce, D; Frick, A; Robinson, J; Rymer, J; Ylikorkala, O1
Birkhaeuser, MH; Davis, S; Mulder, RJ; Nathorst-Böös, J; Nijland, EA; Palacios, S; Schultz, WC; Stathopoulos, VM; van de Weijer, PW; von Mauw, E1
Bjørndal, H; Ma, H; Stuedal, A; Ursin, G1
Alexandrou, A; Christodoulakos, G; Creatsa, M; Grigoriou, O; Kaparos, G; Karaflou, M; Kouskouni, E; Lambrinoudaki, I; Logothetis, E; Panoulis, C1
De Geyter, C; De Napoli, G; de Weerd, V; Foekens, JA; Kloosterboer, HJ; Martens, JW; Sieuwerts, AM; van Galen, A; Zhang, H1
Hirschberg, AL; Lundström, E; Söderqvist, G1
Aravantinos, L; Augoulea, A; Creatsa, M; Kyroudi, A; Lambrinoudaki, I; Panoulis, C; Politi, E; Rizos, D; Sergentanis, TN; Sioulas, VD1
Di Luca, M; Ferrero, S; Leone Roberti Maggiore, U; Remorgida, V; Scala, C; Venturini, PL1
Andrade, AT; Brandão, M; Castro, IQ; Guerra, Mde O; Polisseni, AF; Polisseni, F; Ribeiro, LC1

Reviews

1 review(s) available for tibolone and norethindrone acetate

ArticleYear
[Tibolone].
    Presse medicale (Paris, France : 1983), 2002, Sep-07, Volume: 31, Issue:28

    Topics: Adult; Aged; Animals; Blood Coagulation; Breast; Cardiovascular Diseases; Controlled Clinical Trials as Topic; Double-Blind Method; Endometrium; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Humans; Hysterectomy; Lipid Metabolism; Lipids; Medrogestone; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Osteoporosis, Postmenopausal; Ovariectomy; Placebos; Postmenopause; Progesterone Congeners; Prospective Studies; Rabbits; Rats; Risk Factors; Surveys and Questionnaires; Time Factors

2002

Trials

33 trial(s) available for tibolone and norethindrone acetate

ArticleYear
A prospective randomized controlled study comparing the morphological and biochemical responses of the endometrium to two different forms of 'period-free' hormone replacement therapy.
    Human reproduction (Oxford, England), 1998, Volume: 13, Issue:8

    Topics: CA-125 Antigen; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Glycodelin; Glycoproteins; Humans; Menstruation; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Pregnancy Proteins; Prospective Studies

1998
Effects of tibolone and continuous combined hormone replacement therapy on parameters in the clotting cascade: a multicenter, double-blind, randomized study.
    Fertility and sterility, 2000, Volume: 74, Issue:1

    Topics: Aged; Blood Coagulation; Blood Coagulation Tests; Double-Blind Method; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Fibrinolysis; Hemostasis; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Thromboembolism

2000
Resistance of pelvic arteries and plasma lipids in postmenopausal women: comparative study of tibolone and continuous combined estradiol and norethindrone acetate replacement therapy.
    American journal of obstetrics and gynecology, 2000, Volume: 183, Issue:3

    Topics: Anabolic Agents; Arteries; Estradiol; Female; Humans; Iliac Artery; Lipids; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Pelvis; Postmenopause; Pulsatile Flow; Ultrasonography, Doppler, Color; Uterus; Vascular Resistance

2000
Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy.
    Fertility and sterility, 2001, Volume: 75, Issue:3

    Topics: Androgens; Androstenedione; Dehydroepiandrosterone Sulfate; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Female; Follicle Stimulating Hormone; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Prospective Studies; Sex Hormone-Binding Globulin; Testosterone

2001
Effects of tibolone and continuous combined hormone replacement therapy on mammographic breast density.
    American journal of obstetrics and gynecology, 2002, Volume: 186, Issue:4

    Topics: Biopsy, Needle; Breast; Double-Blind Method; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Humans; Mammography; Norethindrone; Norethindrone Acetate; Norpregnenes; Placebos; Postmenopause; Prospective Studies

2002
Impact of different hormone replacement therapy regimens on the size of myoma uteri in postmenopausal period: tibolone versus transdermal hormonal replacement system.
    Maturitas, 2002, Jul-25, Volume: 42, Issue:3

    Topics: Administration, Cutaneous; Aged; Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Estradiol; Estrogen Replacement Therapy; Female; Humans; Leiomyoma; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Polyps; Postmenopause; Progesterone Congeners; Ultrasonography; Uterine Hemorrhage; Uterine Neoplasms

2002
Effects of tibolone and combined 17beta-estradiol and norethisterone acetate on serum C-reactive protein in healthy post-menopausal women: a randomized trial.
    Human reproduction (Oxford, England), 2002, Volume: 17, Issue:10

    Topics: Adult; C-Reactive Protein; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Weight Gain

2002
Haemostatic risk factors in healthy postmenopausal women taking hormone replacement therapy.
    Maturitas, 2002, Oct-25, Volume: 43, Issue:2

    Topics: Estradiol; Female; Hemostasis; Hormone Replacement Therapy; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Risk Factors; Time Factors

2002
The short-term effects of different regimens of hormone replacement therapy on left ventricular structure and performance in healthy postmenopausal women. A prospective, controlled echocardiographic study.
    Gynecologic and obstetric investigation, 2003, Volume: 55, Issue:3

    Topics: Administration, Cutaneous; Cardiac Output; Estradiol; Estrogen Replacement Therapy; Female; Heart Ventricles; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Prospective Studies; Stroke Volume; Systole; Ultrasonography; Ventricular Function, Left

2003
Changes in body composition during post-menopausal hormone therapy: a 2 year prospective study.
    Human reproduction (Oxford, England), 2003, Volume: 18, Issue:8

    Topics: Adipose Tissue; Alkaline Phosphatase; Body Composition; Bone and Bones; Bone Density; Collagen; Collagen Type I; Estradiol; Estrogen Replacement Therapy; Female; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Osteocalcin; Peptides; Prospective Studies; Thinness

2003
The effects of hormone replacement therapy type on pulmonary functions in postmenopausal women.
    Maturitas, 2003, Nov-20, Volume: 46, Issue:3

    Topics: Adult; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Forced Expiratory Volume; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Prospective Studies; Random Allocation; Vital Capacity

2003
Effects of low-dose 17-beta-estradiol plus norethisterone acetate and tibolone on fasting plasma homocysteine levels in postmenopausal women.
    Acta obstetricia et gynecologica Scandinavica, 2003, Volume: 82, Issue:12

    Topics: Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Estradiol; Fasting; Female; Homocysteine; Hormone Replacement Therapy; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Probability; Reference Values; Sensitivity and Specificity

2003
A comparative study of breast cell proliferation during hormone replacement therapy: effects of tibolon and continuous combined estrogen-progestogen treatment.
    Climacteric : the journal of the International Menopause Society, 2004, Volume: 7, Issue:1

    Topics: Aged; Antibodies, Monoclonal; Biopsy, Needle; Breast; Cell Division; Contraceptives, Oral, Synthetic; Double-Blind Method; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Ki-67 Antigen; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Prospective Studies

2004
Different effects of tibolone and continuous combined estrogen plus progestogen hormone therapy on sex hormone binding globulin and free testosterone levels--an association with mammographic density.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2005, Volume: 20, Issue:2

    Topics: Aged; Breast; Estradiol; Estrogen Replacement Therapy; Female; Gonadal Steroid Hormones; Humans; Insulin-Like Growth Factor I; Mammography; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Testosterone

2005
Evaluation of mammographic density and (99m)Tc-sestamibi scintimammographic uptake in postmenopausal women on hormone replacement therapy.
    Maturitas, 2006, Jan-10, Volume: 53, Issue:1

    Topics: Breast; Chi-Square Distribution; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Follow-Up Studies; Humans; Mammography; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Prospective Studies; Radionuclide Imaging

2006
Effect of different preparations of hormone therapy on lipid and glucose metabolism, coagulation factors, and bone mineral density in overweight and obese postmenopausal women.
    Fertility and sterility, 2005, Volume: 84, Issue:2

    Topics: Adult; Aged; Blood Coagulation Factors; Blood Glucose; Body Mass Index; Bone Density; Contraceptives, Oral, Synthetic; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Lipids; Medroxyprogesterone; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Obesity; Overweight; Pharmaceutical Preparations; Postmenopause

2005
Conventional-dose hormone therapy (HT) and tibolone, but not low-dose HT and raloxifene, increase markers of activated coagulation.
    Maturitas, 2006, Oct-20, Volume: 55, Issue:3

    Topics: Antineoplastic Agents, Hormonal; Blood Coagulation; Blood Coagulation Tests; Bone Density Conservation Agents; Drug Therapy, Combination; Estradiol; Female; Hormone Replacement Therapy; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Raloxifene Hydrochloride; Thromboembolism

2006
Tibolone and estradiol plus norethisterone acetate similarly influence endothelium-dependent vasodilatation in healthy postmenopausal women.
    Fertility and sterility, 2006, Volume: 86, Issue:2

    Topics: Brachial Artery; Drug Combinations; Endothelium, Vascular; Estradiol; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Reference Values; Regional Blood Flow; Vasodilation

2006
Circulating chemoattractants RANTES, negatively related to endogenous androgens, and MCP-1 are differentially suppressed by hormone therapy and raloxifene.
    Atherosclerosis, 2007, Volume: 193, Issue:1

    Topics: Adult; Androgens; Atherosclerosis; Biomarkers; Cardiovascular System; Chemokine CCL2; Chemokine CCL5; Chemotaxis; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators

2007
Differential effects of conventional and low dose oral hormone therapy (HT), tibolone, and raloxifene on coagulation and fibrinolysis.
    Thrombosis research, 2007, Volume: 120, Issue:3

    Topics: Administration, Oral; Aged; Blood Coagulation; Dose-Response Relationship, Drug; Drug Combinations; Estradiol; Estrogen Receptor Modulators; Female; Fibrinolysis; Hormone Replacement Therapy; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Retrospective Studies; Time Factors

2007
Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system.
    Thrombosis and haemostasis, 2007, Volume: 97, Issue:6

    Topics: Activated Protein C Resistance; Administration, Oral; Blood Coagulation; Dose-Response Relationship, Drug; Drug Combinations; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Protein C; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tablets; Thromboembolism; Treatment Outcome; Venous Thrombosis

2007
The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women.
    Climacteric : the journal of the International Menopause Society, 2007, Volume: 10, Issue:5

    Topics: Analysis of Variance; Blood Coagulation; Blood Coagulation Factors; Drug Administration Schedule; Drug Therapy, Combination; Estradiol; Estradiol Congeners; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Fibrinolysis; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Thromboembolism; Venous Thrombosis

2007
Tibolone and low-dose continuous combined hormone treatment: vaginal bleeding pattern, efficacy and tolerability.
    BJOG : an international journal of obstetrics and gynaecology, 2007, Volume: 114, Issue:12

    Topics: Aged; Contraceptives, Oral, Synthetic; Double-Blind Method; Drug Therapy, Combination; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Female; Hot Flashes; Humans; Metrorrhagia; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes

2007
Circulating leptin and ghrelin are differentially influenced by estrogen/progestin therapy and raloxifene.
    Maturitas, 2008, Jan-20, Volume: 59, Issue:1

    Topics: Adult; Body Mass Index; Contraceptives, Oral, Synthetic; Estradiol; Estrogen Receptor Modulators; Estrogens; Estrogens, Conjugated (USP); Fas Ligand Protein; Female; Follicle Stimulating Hormone; Ghrelin; Hormone Replacement Therapy; Humans; Insulin; Leptin; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Raloxifene Hydrochloride; Sex Hormone-Binding Globulin

2008
Tibolone and transdermal E2/NETA for the treatment of female sexual dysfunction in naturally menopausal women: results of a randomized active-controlled trial.
    The journal of sexual medicine, 2008, Volume: 5, Issue:3

    Topics: Administration, Cutaneous; Adult; Dose-Response Relationship, Drug; Drug Therapy, Combination; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Libido; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Sexual Dysfunction, Physiological; Stress, Psychological

2008
Differential impact of conventional and low-dose oral hormone therapy, tibolone and raloxifene on mammographic breast density, assessed by an automated quantitative method.
    BJOG : an international journal of obstetrics and gynaecology, 2008, Volume: 115, Issue:6

    Topics: Administration, Oral; Aged; Breast; Contraceptives, Oral, Synthetic; Drug Combinations; Estradiol; Estrogen Receptor Modulators; Estrogens; Female; Hormone Replacement Therapy; Humans; Mammography; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Organ Size; Postmenopause; Raloxifene Hydrochloride

2008
A comparison of hormone therapies on the urinary excretion of prostacyclin and thromboxane A2.
    Climacteric : the journal of the International Menopause Society, 2008, Volume: 11, Issue:6

    Topics: Cardiovascular Diseases; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Epoprostenol; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Raloxifene Hydrochloride; Thromboxane A2

2008
Improved bleeding profile and tolerability of tibolone versus transdermal E2/NETA treatment in postmenopausal women with female sexual dysfunction.
    Climacteric : the journal of the International Menopause Society, 2009, Volume: 12, Issue:2

    Topics: Administration, Cutaneous; Aged; Breast; Double-Blind Method; Estradiol; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Pain; Postmenopause; Sexual Dysfunction, Physiological; Uterine Hemorrhage

2009
The effect of hormone therapy and tibolone on serum CD40L and ADAM-8 in healthy post-menopausal women.
    Journal of endocrinological investigation, 2010, Volume: 33, Issue:10

    Topics: ADAM Proteins; Adult; Androgen Antagonists; Androstenes; CD40 Ligand; Estradiol; Estrogen Replacement Therapy; Female; Health; Humans; Membrane Proteins; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Progesterone Congeners

2010
Hormone replacement therapy dependent changes in breast cancer-related gene expression in breast tissue of healthy postmenopausal women.
    Molecular oncology, 2011, Volume: 5, Issue:6

    Topics: Breast; Breast Neoplasms; Estradiol; Estrogen Receptor Modulators; Female; Gene Expression Regulation, Neoplastic; Hormone Replacement Therapy; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Prospective Studies; Risk Factors

2011
Digitized assessment of mammographic breast density--effects of continuous combined hormone therapy, tibolone and black cohosh compared to placebo.
    Maturitas, 2011, Volume: 70, Issue:4

    Topics: Breast; Cimicifuga; Contraceptives, Oral, Synthetic; Densitometry; Double-Blind Method; Estradiol; Estrogen Receptor Modulators; Estrogens; Female; Hormone Replacement Therapy; Humans; Mammography; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Plant Preparations; Postmenopause; Radiographic Image Interpretation, Computer-Assisted; Statistics, Nonparametric

2011
Changes in the size of rectovaginal endometriotic nodules infiltrating the rectum during hormonal therapies.
    Archives of gynecology and obstetrics, 2013, Volume: 287, Issue:3

    Topics: Adult; Aromatase Inhibitors; Calcium; Cholecalciferol; Contraceptives, Oral, Sequential; Contraceptives, Oral, Synthetic; Desogestrel; Endometriosis; Estrogen Receptor Modulators; Female; Humans; Image Processing, Computer-Assisted; Letrozole; Nitriles; Norethindrone; Norethindrone Acetate; Norpregnenes; Prospective Studies; Rectal Diseases; Treatment Outcome; Triazoles; Triptorelin Pamoate; Ultrasonography; Vaginal Diseases; Vitamins

2013
Effects of a continuous-combined regimen of low-dose hormone therapy (oestradiol and norethindrone acetate) and tibolone on the quality of life in symptomatic postmenopausal women: a double-blind, randomised study.
    Maturitas, 2013, Volume: 74, Issue:2

    Topics: Affect; Calcium Carbonate; Cholecalciferol; Contraceptives, Oral, Synthetic; Dietary Supplements; Double-Blind Method; Drug Therapy, Combination; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Quality of Life; Sexual Behavior; Statistics, Nonparametric; Surveys and Questionnaires; Vitamins

2013

Other Studies

9 other study(ies) available for tibolone and norethindrone acetate

ArticleYear
Quantitative relationships between steroid structure and binding to putative progesterone receptors.
    Journal of medicinal chemistry, 1977, Volume: 20, Issue:9

    Topics: Androstenes; Animals; Guinea Pigs; Humans; Hydroxyprogesterones; Protein Binding; Rabbits; Receptors, Progesterone; Sheep; Steroids; Structure-Activity Relationship

1977
Serum vascular endothelial growth factor concentrations in postmenopausal women: the effect of hormone replacement therapy.
    Fertility and sterility, 2000, Volume: 73, Issue:1

    Topics: Aged; Cross-Sectional Studies; Endothelial Growth Factors; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Hysterectomy; Levonorgestrel; Lymphokines; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2000
Economic impact of tibolone compared with continuous-combined hormone replacement therapy. In the management of postmenopausal women with climacteric symptoms in the UK.
    PharmacoEconomics, 2000, Volume: 18, Issue:5

    Topics: Anabolic Agents; Drug Costs; Estradiol; Female; Hormone Replacement Therapy; Humans; Markov Chains; Models, Economic; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; United Kingdom

2000
Mammographic density changes during different postmenopausal hormone replacement therapies.
    Fertility and sterility, 2001, Volume: 76, Issue:3

    Topics: Cyproterone Acetate; Drug Combinations; Estradiol; Estriol; Estrogen Replacement Therapy; Estrogens; Female; Humans; Mammography; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Progesterone Congeners; Retrospective Studies; Time Factors

2001
Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene.
    Maturitas, 2005, Apr-11, Volume: 50, Issue:4

    Topics: Adult; Aged; Androgens; Cross-Sectional Studies; Dehydroepiandrosterone Sulfate; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Insulin; Insulin Resistance; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Sex Hormone-Binding Globulin; Testosterone

2005
Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2005, Volume: 20, Issue:3

    Topics: Administration, Cutaneous; Adrenal Glands; Aging; Dehydroepiandrosterone; Estradiol; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Hydrocortisone; Hysterectomy; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Ovariectomy; Postmenopause; Pregnanolone; Progesterone; Progestins

2005
Apoptosis and proliferation in breast cancer cells, cultured in vitro: effects of SERMs.
    Climacteric : the journal of the International Menopause Society, 2005, Volume: 8, Issue:3

    Topics: Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Contraceptive Agents, Female; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Humans; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Norpregnenes; Progesterone; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; Tumor Cells, Cultured

2005
Postmenopausal hormone therapy with estradiol and norethisterone acetate and mammographic density: findings from a cross-sectional study among Norwegian women.
    Climacteric : the journal of the International Menopause Society, 2009, Volume: 12, Issue:3

    Topics: Breast; Contraceptives, Oral, Synthetic; Cross-Sectional Studies; Dose-Response Relationship, Drug; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Female; Humans; Mammography; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Norway; Postmenopause

2009
Does hormone therapy, tibolone or raloxifene modify VEGF expression in cervical epithelial cells?
    Climacteric : the journal of the International Menopause Society, 2012, Volume: 15, Issue:2

    Topics: Aged; Androstenedione; Cervix Uteri; Contraceptives, Oral, Synthetic; Cross-Sectional Studies; Epithelial Cells; Estradiol; Estrogen Antagonists; Estrogen Receptor Modulators; Estrogens; Female; Humans; Metaplasia; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Papanicolaou Test; Postmenopause; Raloxifene Hydrochloride; Statistics, Nonparametric; Vaginal Smears; Vascular Endothelial Growth Factor A

2012